LWM
ANGO icon

Liberty Wealth Management’s AngioDynamics ANGO Stock Holding History

Liberty Wealth Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-342
Closed -$3K – 850
2020
Q2 		$3K Hold
342
– – ﹤0.01% 681
2020
Q1 		$3K Sell
342
-15
-4% -$188 ﹤0.01% 658
2019
Q4 		$6K Hold
357
– – ﹤0.01% 633
2019
Q3 		$7K Buy
357
+168
+89% +$3.29K 0.01% 572
2019
Q2 		$4K Hold
189
– – ﹤0.01% 683
2019
Q1 		$4K Hold
189
– – ﹤0.01% 561
2018
Q4 		$3K Buy
+189
New +$3.91K ﹤0.01% 620

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Liberty Wealth Management's ANGO Position: Q3 2020 in Review

Liberty Wealth Management sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 342 shares — an estimated $3K sold.

Liberty Wealth Management first reported a position in ANGO in Q4 2018 and held it in 7 quarters. The position peaked at $7K in Q3 2019. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

  • Liberty Wealth Management reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
  • Liberty Wealth Management sold 342 AngioDynamics shares in Q3 2020, an estimated $3K.
  • Liberty Wealth Management first reported a position in AngioDynamics in Q4 2018 and held it in 7 quarters.
  • Liberty Wealth Management's AngioDynamics position peaked at $7K in Q3 2019.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on Liberty Wealth Management's 13F filing for Q3 2020, filed 5 Nov 2020.